Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CDK4/6-IN-8 (Compound 7p) is a selective inhibitor of CDK4 (IC50=5.01 nM) and CDK6 (IC50=3.97 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | CDK4/6-IN-8 (Compound 7p) is a selective inhibitor of CDK4 (IC50=5.01 nM) and CDK6 (IC50=3.97 nM). |
In vitro | CDK4/6-IN-8 (Compound 7p) (0-656.1 μM, 48 h) shows anti-breast cancer activity [1]. Cell Viability Assay [1] Cell Line: MCF-7 Concentration: 0.1, 0.3, 0.9, 2.7, 8.1, 24.3, 72.9, 218.7 and 656.1 μM Incubation Time: 48 h Result: Inhibited cell viability with an IC 50 of 2.8 μM. |
Molecular Weight | 398.37 |
Formula | C18H18N6O5 |
CAS No. | 2649120-22-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CDK4/6-IN-8 2649120-22-7 inhibitor inhibit